WHO identifies priority pathogens for new ‘urgently needed’ vaccine development including HIV and malaria 6 November 2024
GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia 3 October 2024
